Does angiotensin-converting enzyme inhibitor and β-blocker use reduce the risk of primary liver cancer? A case-control study using the U.K. Clinical Practice Research Datalink

February 5, 2016Posted inDrug Safety Studies, Drugs and risk of cancer, Select Publications
Journal: Pharmacotherapy Authors: Katrina Wilcox Hagberg, Vikrant V Sahasrabuddhe, Katherine A McGlynn, Susan S Jick NLM Citation: Hagberg KW, Sahasrabuddhe VV, McGlynn KA, Jick SS. Does angiotensin-converting enzyme inhibitor and β-blocker use reduce…

Use of cardiac glycosides and risk of glioma

December 31, 2015Posted inUncategorized
Journal: Journal of Neuro-oncology Authors: Corinna Seliger 1, Christoph R Meier 2 3 4, Susan S Jick 3, Martin Uhl 5, Ulrich Bogdahn 5, Peter Hau 5, M F Leitzmann 6 NLM Citation: Seliger C, Meier CR, Jick SS, Uhl M, Bogdahn U, Hau P,…

Menopausal hormone therapy use and risk of primary liver cancer in the clinical practice research datalink

December 31, 2015Posted inDrug Safety Studies, Drugs and risk of cancer, Safety of other hormone therapies, Select Publications
Journal: International Journal of Cancer Authors: Katherine A McGlynn, Katrina Hagberg, Jie Chen, Megan Braunlin, Barry I Graubard, Neha Suneja, Susan Jick, Vikrant V Sahasrabuddhe NLM Citation: McGlynn KA, Hagberg K, Chen J, Braunlin M, Graubard BI,…

Rates of cardiovascular disease and major adverse cardiovascular events in patients with psoriatic arthritis compared to patients without psoriatic arthritis

December 31, 2015Posted inDisease Epidemiology Studies, Other important conditions, Select Publications
Journal: Journal of Clinical Rheumatology: practical reports of rheumatic & musculoskeletal diseases Authors: Lin Li, Katrina Wilcox Hagberg, Michael Peng, Kamal Shah, Maria Paris, Susan Jick NLM Citation: Li L, Hagberg KW, Peng M, Shah…